Martin J. Gilligan
Corporate Officer/Principal bij PHATHOM PHARMACEUTICALS, INC.
Profiel
Martin J.
Gilligan is currently the Chief Commercial Officer at Phathom Pharmaceuticals, Inc. Previously, he worked as the VP-Inflammation & Immunology at Celgene Corp.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Actieve functies van Martin J. Gilligan
| Bedrijven | Functie | Begin |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06-01-2020 |
Eerdere bekende functies van Martin J. Gilligan
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Opleiding van Martin J. Gilligan
| Rutgers State University of New Jersey | Masters Business Admin |
| Providence College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
